About this trial
The objective of this single center, interventional cohort study is to evaluate the feasibility of remote electrophysiological cardiotocography (eCTG) monitoring in complicated pregnancies in a home@hospital setting.
The primary objective is to assess:
• The success rate of the self-administered eCTG measurement
The secondary objective is to asses:
* Maternal and perinatal outcomes * Patients wellbeing and satisfaction. * Healthcare professionals' (HCPs') satisfaction * Analysis of antenatal costs
Participants will:
* Self-administer remote eCTG monitoring once daily during admission (or at least twice weekly at the outpatient clinic) * Self-measure their blood pressure, heartrate and temperature * Enter the measurements, symptoms and worries into an application on their telephone. * Answer questionnaires at 3 moments during the study, assessing their wellbeing and satisfaction of the received care and self-administered remote monitoring device.
Eligibility criteria
Qualifiers
Minimum age of 18 years old
Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days
Singleton pregnancy
Pre-eclampsia (PE)
Disqualifiers
Oral and written informed consent is obtained.
An indication for intravenous medication
Blood pressure >160/110 A millimeter of mercury (mmHg)
Absent-/or reversed flow umbilical artery Doppler
Trial design
Treatments tested in this trial
- Remote eCTG
Treatment groups
Sponsors and collaborators
Maxima Medical Center
Lead sponsor
Eindhoven University of Technology
Collaborator